Generic Products (November 2017)

NOVEMBER 29, 2017




Medroxyprogesterone Acetate Injectable Suspension, USP
MARKETED BY:
Teva Pharmaceuticals
COMPARE TO: Depo-Provera (Pfizer)
INDICATION: Teva has reintroduced the generic equivalent to Depo-Provera contraceptive injection (medroxyprogesterone ace- tate injectable suspension, USP) 150 mg/mL. Medroxyprogesterone acetate injectable suspension is a progestin indicated only for the prevention of pregnancy.
DOSAGE FORM: Injectable suspension: 150 mg/mL
FOR MORE INFORMATION: tevapharm.com



Dulo​​​xetine
MARKETED BY:
Glenmark Pharmaceuticals
COMPARE TO: Nitrostat (Pfizer) INDICATION: The FDA has approved the generic version of Pfizer’s Nitrostat (nitroglycerin) sublingual tablets USP, 0.3 mg, 0.4 mg, and 0.6 mg. Nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.
DOSAGE FORM: Tablet: 0.3 mg, 0.4 mg, or 0.6 mg
FOR MORE INFORMATION: glenmarkpharma.com



Desonide Ointment, 0.05%
MARKETED BY:
Glenmark Pharmaceuticals
COMPARE TO: Desonide Ointment, 0.05% (Perrigo)
INDICATION: The FDA has approved the generic version of Perrigo’s Desonide Ointment, 0.5%. Desonide Ointment is indicated for the
relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
DOSAGE FORM: Topical
FOR MORE INFORMATION: glenmarkpharma.com



Hydromorphone Hydrochloride 
MARKETED BY: Perrigo
COMPARE TO: Exalgo (Mallinckrodt Pharmaceuticals)
INDICATION: The FDA has approved Perrigo’s AB-rated generic version of Exalgo (hydromorphone HCl) 32 mg extended-release tab- lets. Hydromorphone hydrochloride is indicated for the management
of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period.
DOSAGE FORM: Extended-release tablets: 32 mg
FOR MORE INFORMATION: perrigo.com
 

0
Plantsvszombies.info Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.